More than six years after the emergence of COVID-19, debate over the virus’s origin continues to generate political division, drawing attention away from critical efforts to prevent future pandemics. Neil Vora, a physician and epidemiologist with nearly a decade of experience investigating epidemics for the U.S. Centers for Disease Control and Prevention, argues that the focus on pinpointing COVID-19’s source is largely unproductive and that resources should be redirected toward strengthening global biosecurity.

The precise origin of COVID-19 remains uncertain. While some evidence supports the hypothesis that the virus jumped from infected animals to humans at markets in Wuhan, China, an accidental laboratory release cannot be definitively ruled out. This ambiguity reflects the broader challenges inherent in tracing emerging infectious diseases; even decades after the Ebola virus was discovered, researchers have yet to identify its natural reservoir with certainty.

Vora emphasizes that irrespective of COVID-19’s origin, the situation underscores vulnerabilities in both laboratory safety and wildlife trade regulation. Around the world, more than 50 high-containment Biosafety Level 4 laboratories handle dangerous pathogens under strict protocols designed to minimize risk. Nevertheless, laboratory-associated infections have occurred sporadically since the 1970s, involving pathogens such as anthrax, brucellosis, and smallpox viruses. The increasing global threat of infectious diseases—compounded by technological advances that may be exploited by malicious actors—heightens the need for internationally standardized safety measures in pathogen research, along with requirements for compliance from funding agencies and academic publishers.

In contrast to laboratory accidents, most viral pandemics, including all prior to COVID-19, have resulted from zoonotic spillover events—pathogens crossing from animals to humans. Scientists estimate thousands of unknown viruses circulate in wildlife populations that could potentially infect humans. Human activities such as deforestation, industrial agriculture, and the global wildlife trade create conditions that increase spillover risks by intensifying contact between people and animals and by stressing animal populations.

The international wildlife trade is highlighted as a significant risk factor. Millions of live wild animals are legally shipped worldwide each year to meet demand for exotic pets and foods, often in stressful, unsanitary, and overcrowded conditions that facilitate pathogen transmission. Although legal, the trade is poorly regulated, with minimal disease screening and reliance on self-reporting of animal health. Past incidents, such as the 2003 outbreak of a smallpox-like illness traced to imported African rodents in the United States, illustrate this danger. While the U.S. imposed import restrictions following that event, more comprehensive policies to restrict wildlife imports and regulate the trade are lacking.

Vora contends that political infighting over the pandemic’s origin has weakened public health infrastructure and undermined expertise, complicating current pandemic preparedness and response efforts. Healthcare workers experience burnout, research funding has declined, and public health professionals have been marginalized within federal agencies.

Given these realities, the focus should shift toward implementing robust policies that reduce pandemic risks on multiple fronts, including enhanced biosafety protocols and stringent controls on wildlife trade. As pathogens do not abide by political divisions, Vora highlights the necessity of unified, science-driven approaches to prevent the next global health crisis.